| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |